Kiniksa Pharmaceuticals Ltd (KNSA) is around the top of the Biotechnology industry according to InvestorsObserver. KNSA received an overall rating of 77, which means that it scores higher than 77 percent of all stocks. Kiniksa Pharmaceuticals Ltd also achieved a score of 96 in the Biotechnology industry, putting it above 96 percent of Biotechnology stocks. Biotechnology is ranked 62 out of the 148 industries.
KNSA has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on KNSA!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 77 means the stock is more attractive than 77 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Kiniksa Pharmaceuticals Ltd Stock Today?
Kiniksa Pharmaceuticals Ltd (KNSA) stock has fallen -0.96% while the S&P 500 has risen 0.12% as of 12:04 PM on Friday, Aug 25. KNSA has fallen -$0.17 from the previous closing price of $17.65 on volume of 46,847 shares. Over the past year the S&P 500 has gained 4.35% while KNSA has risen 36.67%. KNSA earned $3.27 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 5.34.
Click Here to get the full Stock Report for Kiniksa Pharmaceuticals Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
